- Home
- CLRB vs CAPT Comparison
CLRB vs CAPT Comparison
Compare CLRB & CAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- CAPT
- Stock Information
- Founded
- CLRB 2002
- CAPT 2005
- Country
- CLRB United States
- CAPT South Korea
- Employees
- CLRB N/A
- CAPT N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- CAPT Blank Checks
- Sector
- CLRB Health Care
- CAPT Finance
- Exchange
- CLRB Nasdaq
- CAPT Nasdaq
- Market Cap
- CLRB 15.3M
- CAPT 12.4M
- IPO Year
- CLRB N/A
- CAPT N/A
- Fundamental
- Price
- CLRB $0.31
- CAPT $0.56
- Analyst Decision
- CLRB Buy
- CAPT
- Analyst Count
- CLRB 2
- CAPT 0
- Target Price
- CLRB $28.00
- CAPT N/A
- AVG Volume (30 Days)
- CLRB 1.4M
- CAPT 14.7M
- Earning Date
- CLRB 03-26-2025
- CAPT 01-01-0001
- Dividend Yield
- CLRB N/A
- CAPT N/A
- EPS Growth
- CLRB N/A
- CAPT N/A
- EPS
- CLRB N/A
- CAPT N/A
- Revenue
- CLRB N/A
- CAPT $17,389,944.00
- Revenue This Year
- CLRB N/A
- CAPT N/A
- Revenue Next Year
- CLRB N/A
- CAPT N/A
- P/E Ratio
- CLRB N/A
- CAPT N/A
- Revenue Growth
- CLRB N/A
- CAPT 84.70
- 52 Week Low
- CLRB $0.22
- CAPT $0.37
- 52 Week High
- CLRB $4.45
- CAPT $6.75
- Technical
- Relative Strength Index (RSI)
- CLRB 46.10
- CAPT 51.73
- Support Level
- CLRB $0.26
- CAPT $0.43
- Resistance Level
- CLRB $0.35
- CAPT $0.48
- Average True Range (ATR)
- CLRB 0.03
- CAPT 0.20
- MACD
- CLRB 0.02
- CAPT 0.01
- Stochastic Oscillator
- CLRB 61.40
- CAPT 10.41
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.